5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
Grundinformationen
- CAS
94666-07-6- Standard-SMILES
CCOc1ccccc1OCCNC(C)Cc1ccc(OC)c(S(N)(=O)=O)c1- InChIKey
DRHKJLXJIQTDTD-UHFFFAOYSA-N- Summenformel
- C20H28N2O5S
- Durchschnittliche Molmasse
- 408,5 g/mol
- Monoisotopische Masse
- 408,17189317
Namen und Bezeichner
- Bevorzugter Name
- 5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide
- IUPAC
- 5-[2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide
- Englischer Name
- (+-)-Tamsulosin
- Summenformel
- C20H28N2O5S
- Molmasse
- 408.51
Namen und Synonyme
Weitere Namen anzeigen
Datenbank-Bezeichner
- CAS
94666-07-6- PubChem CID
- 121829
- ChEBI
CHEBI:142546- EC Number
- 926-076-3
- Nikkaji
- J330.327F
Eigenschaften
Berechnete Struktureigenschaften
- XLogP
- 2,7
- Polarare Oberfläche (TPSA)
- 108 Ų
- H-Brücken-Donoren
- 2
- H-Brücken-Akzeptoren
- 7
- Frei drehbare Bindungen
- 11
- Schwere Atome
- 28
- Formalladung
- 0
- Komplexität
- 539
Physikochemische Eigenschaften
- Siedepunkt
- 595.5 · 595.5±60.0 °C(Predicted)
- Dichte
- 1.191 · 1.191±0.06 g/cm3(Predicted)
- pka
- 10.08 · 10.08±0.60(Predicted)
Sicherheit und Regulatorisches
GHS-Klassifizierung
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 2 reports by companies from 1 notifications to the ECHA C&L Inventory.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Gefahrenhinweise
Regulatorische Informationen
Chemie und Industrie
Pharmakologische Informationen
MeSH Pharmacological Classification
Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS.
Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS.
Anbieter3 Anbieter
Zugehörige Reaktionen
Notizen zur Verbindung
Wird geladen…